A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma

Mycobacterial preparations have been used with limited success against cancer apart from superficial bladder cancer. Recently, a therapeutic vaccine derived from Mycobacterium vaccae has been given to patients with prostate cancer and melanoma indicating a possible beneficial effect on disease activ...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Brien, M E R, Saini, A, Smith, I E, Webb, A, Gregory, K, Mendes, R, Ryan, C, Priest, K, Bromelow, K V, Palmer, R D, Tuckwell, N, Kennard, D A, Souberbielle, B E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374669/
https://www.ncbi.nlm.nih.gov/pubmed/10970684
http://dx.doi.org/10.1054/bjoc.2000.1401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374669/
https://www.ncbi.nlm.nih.gov/pubmed/10970684
http://dx.doi.org/10.1054/bjoc.2000.1401

Ejemplares similares